title: Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia.
authors.affiliation: INCT de Sangue, Hematology and Hemotherapy Center, University of Campinas - UNICAMP, Campinas, SP, Brazil.
authors.forename: Venina M
authors.initials: VM
authors.lastname: Dominical
authors.affiliation: Flow Cytometry Core, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Leigh
authors.initials: L
authors.lastname: Samsel
authors.affiliation: Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: James S
authors.initials: JS
authors.lastname: Nichols
authors.affiliation: INCT de Sangue, Hematology and Hemotherapy Center, University of Campinas - UNICAMP, Campinas, SP, Brazil.
authors.forename: Fernando F
authors.initials: FF
authors.lastname: Costa
authors.affiliation: Flow Cytometry Core, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: J Phillip
authors.initials: JP
authors.lastname: McCoy
authors.affiliation: INCT de Sangue, Hematology and Hemotherapy Center, University of Campinas - UNICAMP, Campinas, SP, Brazil conran@unicamp.br.
authors.forename: Nicola
authors.initials: N
authors.lastname: Conran
authors.affiliation: Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Kato
mesh_terms: D000755:Anemia, Sickle Cell / Q000188:drug therapy / Q000473:pathology*; D000986:Antisickling Agents / Q000627:therapeutic use; D001792:Blood Platelets / Q000378:metabolism*; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009504:Neutrophils / Q000378:metabolism / Q000473:pathology*; D010641:Phenotype
chemical_list: D000986:Antisickling Agents; D015815:Cell Adhesion Molecules; D006918:Hydroxyurea
keywords: circulating neutrophil-red cell heterocellular aggregates; platelets; sickle cell anemia